Fly News Breaks for March 3, 2015
ALKS
Mar 3, 2015 | 06:27 EDT
JPMorgan says yesterday's investor event reinforced its belief that Alkermes is well positioned with a diversified core commercial portfolio, "deep and rapidly maturing" specialized central nervous system pipeline, and "strong" financial position. The firm reiterates an Overweight rating on the stock with a $77 price target.
News For ALKS From the Last 2 Days